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Abstract
Objective:  To  investigate  the  relationship  between  serum  thyrotropin  (TSH),  insulin  resistance
(IR), and  cardiovascular  risk  factors  (CRF)  in  a  sample  of  overweight  and  obese  Brazilian  ado-
lescents.
Methods: A  retrospective,  longitudinal  analysis  of  199  overweight  and  obese  pubescent  ado-
lescents  was  performed.  The  TSH  and  free  T4  (fT4)  levels,  anthropometric  measurements,  and
laboratory  test  results  of  these  patients  were  analyzed.
Results:  27  individuals  (13.56%)  presented  with  TSH  levels  above  the  normal  level  (subclini-
cal hypothyroidism  [SCH]).  Their  waist  circumference  (WC)  was  signiﬁcantly  higher  than  those
of euthyroid  individuals.  Serum  TSH  was  positively  correlated  with  the  homeostasis  model
assessment  of  insulin  resistance  (HOMA-IR)  index,  triglycerides  (TG)  and  high-density  lipopro-
tein cholesterol  (HDL-C).  Using  TSH  and  BMI  as  independent  variables,  TSH  levels  were  shown
to be  independently  related  to  HOMA-IR  (p  =  0.001)  and  TG  (p  =  0.007).  Among  euthyroid  sub-
jects, individuals  with  TSH  values  <2.5  mIU/mL  exhibited  statistically  signiﬁcant  decreases  in
waist-to-hip  ratio,  HDL-C  levels,  and  HOMA-IR  scores  and  a  tendency  toward  lower  WC  values.
Conclusion:  SCH  in  overweight  and  obese  adolescents  appears  to  be  associated  with  excess
weight, especially  visceral  weight.  In  euthyroid  adolescents,  there  appears  to  be  a  direct  rela-
tionship between  TSH  and  some  CRF.  In  conclusion,  in  the  present  sample  of  overweight  and
obese adolescents,  TSH  levels  appear  to  be  associated  with  IR  and  CRF.
© 2016  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  This  is  an  open
access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
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Níveis  de  TSH  sérica  associados  a  fatores  de  risco  cardiovascular  em  adolescentes
acima  do  peso  e  obesos
Resumo
Objetivo:  Investigar  a  relac¸ão  entre  tireotroﬁna  sérica  (TSH),  resistência  à  insulina  (RI)  e  fatores
de risco  cardiovascular  (FRC)  em  uma  amostra  de  adolescentes  brasileiros  acima  do  peso  e
obesos.
Métodos: Foi  realizada  uma  análise  longitudinal  retrospectiva  de  190  adolescentes  púberes
acima do  peso  e  obesos.  Foram  analisados  os  níveis  de  TSH  e  T4  livre  (T4l),  as  medidas
antropométricas  e  os  resultados  de  exames  laboratoriais  desses  pacientes.
Resultados:  27  indivíduos  (13,56%)  apresentaram  níveis  de  TSH  acima  do  normal
(hipotireoidismo  subclínico  (HSC)).  Eles  apresentaram  circunferência  da  cintura  (CC)  signiﬁcati-
vamente  maior  que  os  indivíduos  eutireoideos.  A  TSH  sérica  foi  positivamente  correlacionada  ao
índice do  modelo  de  avaliac¸ão  da  homeostase  de  resistência  à  insulina  (HOMA-IR),  triglicerídeos
(TG) e  lipoproteína  de  alta  densidade-colesterol  (HDL-C).  Usando  TSH  e  IMC  como  var-
iáveis independentes,  os  níveis  de  TSH  estavam  relacionados  ao  HOMA-IR  (p  =  0.001)  e  a
TG (p  =  0.007)  de  forma  independente.  Entre  os  pacientes  eutireoideos,  indivíduos  com  val-
ores de  TSH  <  2.5  mIU/mL  apresentaram  reduc¸ões  estatisticamente  signiﬁcativas  na  razão
cintura/quadril,  nos  níveis  de  HDL-C  e  nos  escores  de  HOMA-IR  e  tendência  a  menores  valores
de CC.
Conclusão:  O  HSC  em  adolescentes  acima  do  peso  e  obesos  parece  estar  associado  ao  excesso
de peso,  principalmente  de  peso  visceral.  Em  adolescentes  eutireoideos,  parece  haver  uma
relac¸ão direta  entre  TSH  e  alguns  FRC.  Concluindo,  em  nossa  amostra  de  adolescentes  acima
do peso  e  obesos,  os  níveis  de  TSH  parecem  estar  associados  a  RI  e  FRC.
© 2016  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  Este e´  um  artigo
Open Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-nc-nd/4.
0/).
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Janeiro,  Brazil),  from  March  of  2011  to  February  of  2013.  TheIntroduction
The  incidence  of  obesity  in  childhood  and  adolescence  is
increasing  in  developing  and  developed  countries.1 In  Brazil,
a  developing  country,  data  from  the  Household  Budget  Sur-
vey  (Pesquisa  de  Orc¸amentos  Familiares  [POF])  showed  that
the  percentage  of  overweight  individuals  between  the  ages
of  10  and  19  increased  from  3.7%  (1974--1975)  to  21.7%
(2008--2009)  in  males  and  from  7.6%  to  19.4%  in  females  in
the  same  periods.2
The  well-established  association  between  obesity  and
glucose/lipid  metabolism  disorders,  hypertension  and
increased  cardiovascular  risk  (CVR)  is  frequently  referred
to  as  metabolic  syndrome  (MetS).3 Individuals  in  the  pedi-
atric  age  group  may  also  show  increased  MetS-related
morbidity.3--5
Thyroid  hormones  (TH)  play  a  key  role  in  regulating
metabolism  through  the  modulation  of  thermogenesis  and
energy  expenditure.  The  putative  relationships  between  TH,
body  weight,  and  adipose  tissue  homeostasis  have  been  the
focus  of  several  studies  in  recent  years,  but  the  causal  rela-
tionships  between  these  parameters  have  not  been  well
established.6--12 One  review8 included  several  population-
based  studies  that  revealed  a  correlation  between  increased
serum  thyrotropin  (TSH)  levels  and  increased  BMI.
Thyroid  diseases  have  been  associated  with  atheroscle-
rotic  cardiovascular  disease.13--16 Although  this  association
has  been  documented  conclusively  for  overt  hypothy-
roidism,  it  remains  controversial  whether  it  is  also  present
in  subclinical  hypothyroidism  (SCH).17,18 The  association  of
p
t
thyroid  diseases  with  atherosclerotic  cardiovascular  disease
ay  be  partially  explained  by  the  roles  of  TH  in  the  regu-
ation  of  lipid  metabolism  and  blood  pressure  (BP).  Indeed,
everal  recent  population-based  studies  have  observed  pos-
tive  correlations  between  TSH  and  lipid  parameters  and
etween  TSH  and  BP,  even  in  euthyroid  populations.6--18 This
tudy  aimed  to  investigate  the  relationship  between  thyroid
unction,  obesity,  lipids,  insulin  resistance,  and  MetS  com-
onents  in  a  sample  of  overweight  adolescents.  The  study
lso  aimed  to  assess  the  metabolic  and  anthropometric  dif-
erences  of  euthyroid  patients  with  TSH  in  the  upper  limit
f  normality  (≥2.5  IU/mL)  in  comparison  to  patients  in  the
ower  levels.
atients and methods
ubjects
his  study  evaluated  a  total  of  199  overweight  and  obese
ubescent  adolescents  of  both  genders  between  11  and
7  years  of  age  (from  Tanner  stage  II  or  post-pubertal
tage)  who  sequentially  sought  treatment  for  obesity  at  the
etabolic  Outpatient  Clinic  of  the  Luiz  Capriglione  State
nstitute  of  Diabetes  and  Endocrinology  (Instituto  Estadual
e  Diabetes  e  Endocrinologia  Luiz  Capriglione  [IEDE],  Rio  derotocol  was  approved  by  the  Ethics  Committee  of  the  Insti-
ution  and  a written  informed  consent  was  obtained  from
he  participants  and  their  parents/guardians.
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This  exclusion  criteria  included  the  following:  pre-
ubertal  patients;  previous  diagnosis  of  either  type  1  or
ype  2  diabetes  (T2DM);  patients  who  were  receiving  anti-
iabetic  and/or  anti-obesity  medications;  those  who  had
n  endocrine  disease  diagnosis;  diagnosed  thyroid  disease
the  use  of  levothyroxine  (LT4)  or  thionamides);  creatinine
nd  urea  levels  above  normal  values;  aspartate  amino-
ransaminase  (AST)  and/or  aspartate  alaninotransferase
ALT)  three  times  above  the  upper  limit  of  normality;  alcohol
r  drug  abuse;  chronic  and  constant-dose  concomitant  use
f  beta-blockers,  beta-agonists,  diuretics,  antidepressants,
euroleptics,  bromocriptine,  ergotamine,  and  derivatives,
tropine,  systemic  steroids,  appetite  suppressants,  or  drugs
hat  interfere  with  amine  activity  or  are  used  to  treat  psy-
hiatric  disorders  within  the  past  three  months;  pregnant
nd  lactating  females;  or  a  history  of  neoplasia  in  the  past
ve  years.
nthropometric  examination
ll  participants  underwent  a  complete  medical  history-
aking  and  physical  exam.  Family  members  and/or  guardians
ssisted  in  providing  information  after  signing  the  informed
onsent  form.  The  following  parameters  were  evaluated:
eight  (kg),  height  (m),  body  mass  index  (BMI;  kg/m2),  waist
ircumference  (WC),  waist-to-hip  ratio  (WHR),  BP  (mmHg),
nd  demographic  factors  (gender  and  age).  Weight  measure-
ents  were  obtained  using  a  digital  scale  Filizola® (Filizola®,
P,  Brazil)  while  each  patient  was  barefoot  and  wearing  light
lothing.  The  height  of  each  patient  was  measured  using
 Harpenden® (Harpenden®,  United  Kingdom)  stadiometer
ith  the  individual  barefoot.  WC  was  measured  at  the  mid-
oint  between  the  iliac  crest  and  the  costal  margin.  Hip
ircumference  (HC)  was  obtained  by  measuring  the  largest
iameter  over  the  great  trochanters.  The  WHR  was  calcu-
ated  by  determining  the  ratio  between  WC  and  HC.  BMI  was
alculated  by  dividing  the  weight  (kg)  by  the  height  squared
m2).
The  American  charts  from  the  Centers  for  Dis-
ase  Control  and  Prevention  National  Center  for
ealth  Statistics  (CDC-NCHS)  were  used  to  assess  BMI
http://apps.nccd.cdc.gov/dnpabmi/),  according  to  gen-
er  and  age.  Individuals  with  a  BMI-for-age  between  the
5th  and  the  95th  percentile  were  classiﬁed  as  overweight
nd  those  with  a  BMI-for-age  at  or  above  the  95th  per-
entile  were  classiﬁed  as  obese  BP  was  obtained  with  the
atient  in  a  supine  position  after  5  min  of  rest.  All  BP
easurements  were  obtained  by  the  same  examiner  using
he  same  equipment.  For  BP  measurements,  a  standardized
nd  calibrated  mercury-column  sphygmomanometer  was
sed  with  the  cuffs  adjusted  to  the  body  dimensions.  All
nthropometric  measurements  were  evaluated  by  the  same
xaminer,  and  the  sexual  maturation  stage  was  determined
sing  the  Tanner  classiﬁcation  of  pubertal  development.
aboratory  evaluationslood  samples  were  collected  after  a  12-h  fasting  period,
nd  the  results  from  the  following  blood  tests  were  evalu-
ted:  fasting  glucose,  2-h  glucose  following  glucose  overload
ith  75  g  dextrosol,  complete  blood  count,  urea,  creatinine,
R
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odium,  potassium,  total  cholesterol,  high-density  lipopro-
ein  cholesterol  (HDL-C),  low-density  lipoprotein  cholesterol
LDL-C),  triglycerides,  ALT,  AST,  TSH,  free  T4  (fT4),  and
asal  insulin.  Using  the  results  of  fasting  glucose  and  basal
nsulin,  the  homeostasis  model  assessment-insulin  resis-
ance  (HOMA-IR)  index  for  each  patient  was  calculated  using
he  following  formula:  HOMA-IR  =  [Glucose  (mMol)  ×  Insulin
U/mL)]/22.5.  The  Brazilian  Metabolic  Syndrome  Study
BRAMS)  evaluated  a  population  of  approximately  2000
atients,  including  obese  and  type  2  diabetic  adults,  and
eﬁned  insulin  resistance  (IR)  as  a  HOMA-IR  index  value
reater  than  2.71  in  individuals  with  normal  BMI.19 This  cut-
ff  for  HOMA-IR  is  likely  to  be  representative  of  the  Brazilian
opulation,  given  the  number  of  patients  evaluated.
To  evaluate  TSH  levels,  an  electrochemiluminescence
ethod  was  employed.  Electrochemiluminescence  consists
f  an  immunoassay  that  quantitatively  determines  TSH  lev-
ls  from  human  serum  and  plasma  samples.  The  normal
ange  of  values  that  have  been  reported  using  this  kit  is
.5--5.0  IU/mL.  The  fT4  levels  of  the  patients  were  also
valuated  by  electrochemiluminescence,  and  the  reference
alues  ranged  between  0.8  and  1.9  ng/mL.  The  fT4  values
ere  only  used  to  exclude  patients  in  the  event  that  values
utside  of  the  normal  range  were  obtained.
For  the  diagnosis  of  SCH  in  adolescents,  it  would  be  nec-
ssary  to  use  speciﬁc  values  according  to  gender,  age,  and
anner  stage.  However,  these  data  are  not  available  for  the
razilian  population.  Therefore,  the  diagnosis  of  SCH  was
ased  on  the  recommendation  14.1  of  the  Clinical  Practice
uidelines  for  Hypothyroidism  in  Adults,  cosponsored  by  the
merican  Association  of  Clinical  Endocrinologists  and  the
merican  Thyroid  Association20: the  reference  range  of  a
iven  laboratory  exam  should  determine  the  upper  limit
f  normal  for  a  third-generation  TSH  assay.  Therefore,  the
iagnosis  of  SCH  was  deﬁned  as  normal  fT4  associated  with
SH  above  5.0  IU/mL.
Euthyroid  patients  were  also  divided  into  two  groups
ccording  to  TSH  levels.  There  has  been  some  discussion
bout  lowering  the  upper  value  of  TSH  to  2.5  IU/mL.  This
iscussion  is  based  in  some  data  that  indicated  that  patients
ith  TSH  ≥  2.5  may  have  different  proﬁles  than  those  with
SH  <  2.5  IU/mL.21,22
tatistical  analysis
ata  were  analyzed  using  the  GraphPad® InStat  3.00
GraphPad® Software,  USA).  The  different  groups  were
ompared  using  Student’s  t-tests  for  parametric  varia-
les  and  Mann--Whitney  tests  for  nonparametric  variables.
or  parametric  variables,  the  data  are  presented  as
eans  ±  standard  deviations.  For  nonparametric  variables,
he  data  are  presented  as  medians  with  maximum  and  min-
mum  values.  Correlational  analyses  were  performed  with
earson’s  test  for  parametric  variables  and  Spearman’s  test
or  nonparametric  variables.  All  tests  were  two-tailed,  and
he  level  of  signiﬁcance  was  set  at  p  =  0.05  for  all  analyses.esults
 total  of  199  adolescents  examined  at  the  State  Institute  for
iabetes  and  Endocrinology  were  consecutively  evaluated.
TSH  and  cardiovascular  risk  factors  in  overweight  adolescents  
Table  1  Anthropometric  and  metabolic  data  of  the  studied
sample.
Anthropometric  and
laboratorial  data
Median  Variation
(minimum  to
maximum)
Age  14  11--17
BMI (kg/m2)  34.5  23.4--52.6
Female  (n,  %)a 130  (65.3)
WC  (cm)  102  81--147
WHRb 0.90  ±  0.07
SBP  (mmHg) 120  60--150
DBP (mmHg) 70  50--100
HDL-C  (mg/dL) 41  20--79
TG (mg/dL)  130.0  93.5--334.0
Glucose  (mg/dL)  86.5  68.0--323.0
2-h glucose  (mg/dL) 100  42--252
HOMA-IR  3.4  0.3--30.6
BMI, body mass index; WC, waist circumference; WHR, waist-
to-hip ratio; SBP, systolic blood pressure; DBP, diastolic blood
pressure; HDL-C, high-density lipoprotein cholesterol; TG,
triglycerides; HOMA-IR, homeostasis model assessment-insulin
resistance.
a Data for female gender is presented as the number of indi-
viduals and percentage.
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db Data for WHR are expressed as the mean ± standard deviation
because the sample has a parametric distribution.
All  patients  were  above  Tanner  stage  II  for  pubertal  devel-
opment.  The  frequency  of  overweight  was  6.97%  according
to  the  CDC-NCHS  chart,  and  obesity  was  present  in  93.03%  of
patients.  Table  1  shows  the  anthropometric  and  metabolic
data  of  the  studied  population.Regarding  glucose  metabolism,  13.56%  of  the  sample
(27  out  of  199)  had  abnormal  fasting  glucose  levels  (i.e.,
between  100  and  125  mg/dL).  In  addition,  6.03%  (12  out
of  199)  had  a  2-h  glucose  level  following  a  challenge  with
a
a
p
d
Table  2  A  comparison  of  metabolic  and  anthropometric  paramete
and those  with  normal  thyroid  function.
Normal  (n  =  170)  
Age  (years)  14.0  (11--17)  
BMI (kg/m2)  34.2  (23.4--52.6)  
WC (cm)  102  (72--148)  
WHR 0.91  ±  0.08  
SBP (mmHg)  120  (80--160)  
DBP (mmHg)  70  (50--100)  
Glucose (mg/dL)  87.0  (68--323)  
2-h glucose  (mg/dL)  102.0  (42--252)  
HOMA-IR 3.4  (0.2--50.7)  
AST (mg/dL)  19  (7--67)  
ALT (mg/dL)  16  (6--80)  
TG (mg/dL)  95.0  (30--356)  
HDL-C (mg/dL) 41.5  (20--74)  
LDL-C (mg/dL) 94.1  ±  25.3
BMI, body mass index; WC, waist circumference; WHR, waist-to-hip r
HOMA-IR, homeostasis model assessment-insulin resistance; TG, trigly
transferase; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-de
Data are presented as median (minimum − maximum).535
5  g  dextrosol  between  140  and  200  mg/dL  and  were  thus
lassiﬁed  as  having  impaired  glucose  tolerance.  Finally,  four
atients  (2.02%)  received  a  diagnosis  of  T2DM.  Using  the
utoff  point  for  IR  that  was  obtained  in  the  aforemen-
ioned  Brazilian  study  (a  HOMA-IR  value  above  2.7),  61.19%
122  out  of  199)  of  the  patients  presented  IR.  No  changes
n  fasting  glucose  or  OGTT  were  observed  in  overweight
atients.
Thyroid  function  was  evaluated  by  measuring  TSH  lev-
ls  (normal  range:  0.5--5.0  IU/mL).  Two  (1.0%)  individuals
xhibited  TSH  levels  below  the  normal  range  (subclinical
yperthyroidism),  and  27  individuals  (13.56%)  presented
ith  TSH  levels  above  the  normal  level  (SCH).  All  these
atients  had  fT4  within  normal  limits.  No  patient  was
iagnosed  with  overt  hypothyroidism  (low  fT4  and  TSH
bove  5.0  IU/mL).  Patients  with  subclinical  hyperthy-
oidism  (n  =  2)  were  not  included  in  the  analysis.
Table  2  shows  a  comparison  of  the  anthropometric  and
etabolic  parameters  of  adolescents  diagnosed  with  SCH
nd  euthyroid  adolescents.  Patients  with  SCH  exhibited  a
igniﬁcantly  higher  WC  than  those  with  normal  thyroid  func-
ion.  No  signiﬁcant  differences  were  observed  between  the
roups  in  any  of  the  metabolic  parameters  examined.
After  excluding  patients  with  SCH,  the  170  remaining
atients  (TSH  levels  within  the  normal  range)  were  analyzed
eparately.  Table  3  shows  the  correlations  between  TSH  lev-
ls  and  various  anthropometric  and  metabolic  parameters  in
ndividuals  with  normal  thyroid  function.
Multiple  linear  regression  analysis  was  used  to  assess
he  relationship  between  TSH  and  metabolic  parameters.
n  this  ﬁrst  model,  TSH  and  BMI  were  used  as  independent
ariables  and  each  metabolic  parameter  as  the  dependent
ariable.  After  regression,  TSH  levels  remained  indepen-
ently  associated  with  HOMA-IR  (p  =  0.001),  HDL  (p  =  0.046),
nd  TG  levels  (p  =  0.007).  The  same  analysis  was  also  used  to
ssess  whether  the  relationship  between  TSH  and  metabolic
arameters  would  remain  statistically  signiﬁcant  indepen-
ent  of  age  and  gender.  In  this  second  model,  age,  gender,
rs  between  adolescents  with  subclinical  hypothyroidism  (SCH)
SCH  (n  =  29)  p
14.0  (12--18)  0.33
37.2  (25.8--51.9)  0.046
111  (81--134)  0.0027
0.93  ±  0.05  0.22
120  (90--160)  0.48
80  (50--100)  0.34
91.0  (75--268)  0.087
107.0  (72--200)  0.38
3.7  (1.0--30.5)  0.19
21  (13--39)  0.18
20  (9--54)  0.09
100.0  (30--210)  0.26
40.0  (26--79)  0.11
99.8  ±  24.8  0.26
atio; SBP, systolic blood pressure; DBP, diastolic blood pressure;
ceride; AST, aspartate aminotransferase; ALT, aspartate alanine
nsity lipoprotein cholesterol.
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Table  3  Correlations  between  serum  thyrotropin  (TSH)  lev-
els and  various  anthropometric  and  metabolic  parameters  in
170 adolescents  with  normal  thyroid  function.
Correlation  p-Value
Age  (years)  −0.11  0.13
BMI (kg/m2)  0.14  0.068
WC (cm)  0.11  0.13
WHR 0.05  0.49
Glucose  (mg/dL)  0.13  0.077
2-h glucose  (mg/dL)  0.06  0.44
HOMA-IR  0.16 0.03
TG  (mg/dL) 0.16 0.028
HDL-C  (mg/dL) −0.14 0.055
LDL-C  (mg/dL)  0.03  0.64
BMI, body mass index; WC, waist circumference; WHR, waist-
to-hip ratio; HOMA-IR, homeostasis model assessment-insulin
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niﬁcant  relationship  with  WC. Interestingly,  althoughresistance; TG, triglycerides; HDL-C, high-density lipoprotein
cholesterol; LDL-C, low-density lipoprotein cholesterol.
nd  TSH  levels  were  used  as  independent  variables  and
ach  metabolic  parameters  as  the  dependent  variable.  After
egression,  TSH  remained  independently  related  to  HOMA-
R  (p  =  0.0015)  and  triglycerides  (p  =  0.0092).  A  trend  toward
igniﬁcance  was  still  found  for  HDL  cholesterol  (p  =  0.0508)
nd  fasting  glucose  (p  =  0.0706).
Table  4  shows  a  comparison  of  anthropometric  and
etabolic  parameters  of  individuals  with  normal  thyroid
unction  based  on  a  TSH  cutoff  value  of  2.5  IU/mL.  Indi-
iduals  with  TSH  levels  >2.5  had  higher  WHR  and  HOMA-IR
nd  a  trend  toward  higher  WC.
iscussion
n  this  sample  of  obese  and  overweight  adolescents,  85%
f  patients  exhibited  normal  thyroid  function  and  13.63%
xhibited  SCH.  The  frequency  of  SCH  observed  in  this  sample
as  higher  than  that  reported  in  the  literature,  even  using
 cutoff  value  of  5.0  IU/mL.  In  the  pediatric  population
n  general,  the  prevalence  of  SCH  is  less  than  2%,  but  it  is
s
w
P
Table  4  Comparison  of  anthropometric  and  metabolic  paramet
cutoff level.
TSH  <  2.5  (n  =  60)  
Age  (years)  14.0  (12--17)  
BMI (kg/m2)  34.1  (23.4--50.2)  
Waist (cm)  100.9  ±  13.6  
WHR 0.89  ±  0.08  
Glucose (mg/dL)  87.0  (72--323)  
2-h glucose  (mg/dL)  101.0  (43--166)  
HOMA-IR 2.71  (0.37--17.22)  
TG (mg/dL) 93.0  (36--214)  
HDL-C (mg/dL) 45.0  (27--74)
LDL-C (mg/dL) 92.1  ±  25.2  
Data are presented as median (minimum--maximum), except for waist
BMI, body mass index; WHR, waist-to-hip ratio; HOMA-IR, homeostasi
high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein chSouza  LL  et  al.
mportant  to  note  that  epidemiological  studies  in  this  age
roup  are  scarce.
Several  studies  have  indicated  a  positive  correlation
etween  weight  and  TSH  levels  in  children.  These  stud-
es  have  also  demonstrated  that  10--23%  of  obese  children
ave  moderately  high  levels  of  TSH  (4--10  IU/mL),  which
re  associated  with  normal  levels  of  fT4  or  slightly  elevated
T4  and/or  fT3  levels.  The  levels  of  TSH  in  obese  children
nd  adults  have  been  consistently  reported  to  be  elevated
hen  compared  with  normal  weight  individuals.8,9,12,23,24
rior  research  has  revealed  not  only  a  positive  correlation
etween  BMI  and  TSH,  but  also  between  ﬁve-year  weight
ain  and  a  gradual  increase  in  serum  TSH  levels.8 This  is  the
rst  study  to  evaluate  TSH  levels  in  a  South  American  popu-
ation  of  obese  children.  Considering  that  Rio  de  Janeiro  is  at
n  urban  area  in  Brazil,  with  no  iodine  deﬁciency,  no  reason-
ble  explanation  for  the  elevated  prevalence  of  SCH  found
n  the  present  study  could  be  identiﬁed.  Further  studies  are
ecessary  to  investigate  whether  the  prevalence  of  SCH  is
igher  in  Brazil  and/or  other  South  American  countries.
When  patients  with  SCH  were  compared  with  euthy-
oid  individuals,  it  was  observed  that  patients  with  SCH
ad  higher  WC.  This  ﬁnding  is  extremely  important,  as  WC
rovides  information  regarding  the  fat  distribution.  The
revalence  of  a  central  distribution  of  fat  correlates  with
ncreased  CVR,  and  WC  appears  to  be  the  best  anthropo-
etric  method  for  evaluating  this  distribution  in  pubertal
dolescents  and  children,  although  this  remains  open  to
ebate.6,25 Central  or  abdominal  obesity,  which  is  character-
zed  by  increased  WC,  has  been  shown  to  be  correlated  with
BP,  DBP,  total  cholesterol,  TGs,  LDL-C,  and  HDL-C.4--8 In  an
rticle  published  by  Blüher  et  al.,  BMI  and  WC  were  reported
o  be  the  best  anthropometric  predictors  of  comorbidities
n  obese  pubertal  adolescents.25 Thus,  the  correlation  of
SH  with  WC  contributes  to  its  possible  relationship  with
R  and  increased  CVR.  Several  studies  in  children  and  ado-
escents  have  demonstrated  the  relationship  between  TSH
nd  BMI,  but  few  of  these  have  reported  a  statistically  sig-
26--28everal  anthropometric  parameters  of  adolescents  with  SCH
ere  altered,  no  laboratory  abnormalities  were  observed.
erhaps  these  data  suggest  that,  at  this  early  time  of  life,
ers  in  adolescents  according  to  the  serum  thyrotropin  (TSH)
TSH  ≥  2.5  (n  =  110)  p
14.0  (11--17)  0.024
34.5  (23.9--52.6)  0.11
105.3  ±  14.3  0.054
0.92  ±  0.07  0.04
87.0  (68--133)  0.55
102.5  (42--252)  0.53
3.51  (0.20--50.70)  0.028
95.0  (30--356)  0.25
40.0  (20--68)  0.023
95.1  ±  25.4  0.46
, WHR, and LDL--C, which are presented as mean ± SD.
s model assessment-insulin resistance; TG, triglycerides; HDL-C,
olesterol.
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8. Knudsen N, Laurberg P, Rasmussen LB, Bülow I, Perrild H, Ovesen
L, et al. Small differences in thyroid function may be impor-TSH  and  cardiovascular  risk  factors  in  overweight  adolescen
excess  weight  and  visceral  fat  may  not  be  sufﬁcient  to  trig-
ger  metabolic  changes.  However,  it  is  possible  that  these
changes  will  be  identiﬁed  in  the  future.  Prospective  studies
are  needed  to  evaluate  this  hypothesis.
In  the  euthyroid  individuals,  a  weak,  but  statistically
signiﬁcant,  correlation  was  observed  between  TSH  and
HOMA-IR,  HDL,  and  TG.  Using  TSH  and  BMI  as  indepen-
dent  variables,  TSH  was  found  to  be  independently  related
to  HOMA-IR  and  TG.  An  Italian  study  that  also  made  this
comparison  in  overweight  children  showed  that  patients
with  high  TSH  levels  had  signiﬁcantly  higher  levels  of  ALT,
gamma-glutamyl  transferase  (GGT),  total  cholesterol,  TG,
insulin,  and  HOMA-IR.26 Likewise,  in  a  Turkish  study,  TSH
was  positively  correlated  with  total  cholesterol,  TG,  and
SBP.27 Another  study  of  euthyroid  obese  adolescents  and  chil-
dren  who  underwent  rapid  weight  loss  concluded  that  the
decrease  in  TSH  resulted  in  a  reduction  of  over  50%  in  the
levels  of  fasting  insulin  and  HOMA-IR  regardless  of  changes
in  weight  or  body  composition.  This  improvement  was  not
associated  with  weight  loss,  but  with  a  reduction  in  serum
TSH  levels.  These  data  suggest  that  alterations  of  thyroid
function  in  obesity  are  not  simply  adaptive  mechanisms.28
Even  when  examining  only  euthyroid  patients,  individuals
with  higher  TSH  levels  (>2.5  IU/mL)  had  higher  HOMA-IR
and  WHR,  lower  levels  of  HDL-C,  and  a  tendency  toward
lower  WC.  There  have  been  relatively  few  studies  investi-
gating  euthyroid  obese  adolescents,  but  the  correlation  of
HOMA-IR  with  TSH  has  been  reported  in  several  studies.26--28
Ruhla  et  al.13 found  that  euthyroid  individuals  with  TSH  in
the  upper  normal  range  (2.5--4.5)  have  higher  TG  levels  and
an  increased  incidence  of  MetS.  Roos  et  al.  also  reported  an
association  between  MetS  components  and  thyroid  function
in  individuals  with  SCH  and  in  euthyroid  individuals.  In  this
study,  euthyroid  patients  with  TSH  in  the  upper  portion  of
the  normal  range  displayed  higher  levels  of  total  cholesterol,
glucose,  insulin,  and  HOMA-IR.29
The  aforementioned  evidence,  in  addition  to  the  present
results,  reinforces  the  relationship  between  thyroid  func-
tion,  especially  TSH  levels,  and  IR.  In  patients  with
hypothyroidism,  IR  has  been  well  documented  in  muscle
and  fat  tissue,  and  it  results  in  impaired  glucose  absorp-
tion  and  decreased  gluconeogenesis  in  skeletal  muscle.25
These  metabolic  changes  have  been  shown  to  be  reversed
with  LT4  replacement  therapy.  Several  studies  have  also
reported  the  presence  of  IR  in  SCH.6,15 When  assessing  the
lipid  proﬁles  of  patients  with  SCH,  most  studies  have  not
found  signiﬁcant  differences  in  the  mean  total  cholesterol
levels  of  SCH  patients  when  compared  with  euthyroid  indi-
viduals,  although  some  studies  have  noted  differences  in  the
frequency  of  dyslipidemia  between  these  groups.30
The  present  study  has  several  limitations.  First,  the  fact
that  it  was  a  cross-sectional  study  prevented  the  estab-
lishment  of  temporal  relationships  between  the  variables
under  investigation.  In  addition,  because  this  study  was
performed  retrospectively,  the  authors  were  unable  to  ana-
lyze  other  parameters,  including  the  levels  of  fT3,  tT3,
and  leptin.  More  importantly,  thyroid  antibodies  were  also
not  evaluated.  Therefore,  it  was  not  possible  to  determine
whether  this  increased  frequency  of  SCH  was  related  to
Hashimoto’s  thyroiditis  or  another  etiology.  A  longitudinal
study  that  follows  each  group  over  a  given  period  and  makes
repeated  evaluations  and  observations  may  lead  to  different537
onclusions;  future  studies  are  therefore  needed.  Finally,
he  diagnosis  of  SCH  should  have  been  based  on  speciﬁc
alues  of  TSH  according  to  gender,  age,  and  Tanner  stage.
nfortunately,  these  data  are  not  available  for  the  Brazilian
opulation.  Therefore,  the  diagnosis  was  based  solely  in  the
utoff  value  of  the  kit.
In  summary,  the  frequency  of  SCH  is  approximately  15%
n  a  sample  of  overweight  and  obese  Brazilian  adolescents.
hese  individuals,  despite  exhibiting  a  metabolic  condition
imilar  to  that  of  patients  with  normal  thyroid  function,  have
 higher  WC,  suggesting  that  SCH  may  be  associated  with
xcess  body  weight,  especially  visceral  weight.  In  adoles-
ents  with  normal  thyroid  function,  there  also  appears  to
e  a  direct  relationship  between  TSH  and  some  of  the  pri-
ary  markers  of  IR  and  MetS.  These  correlations,  although
tatistically  signiﬁcant,  were  weak  and  should  be  carefully
nterpreted.  In  particular,  patients  with  TSH  in  the  upper
ormal  limit  appear  to  have  a worse  metabolic  proﬁle,
uggesting  that  thyroid  function  may  be  one  of  the  deter-
inants  of  IR  and  MetS  in  this  sample.  However,  the  clinical
igniﬁcance  of  these  ﬁndings  needs  to  be  determined  in
rospective  studies.  It  will  be  especially  important  to  per-
orm  large  studies  examining  the  potential  advantages  of
reating  obese  children  and  adolescents,  targeting  a  TSH  of
pproximately  2.5  to  attenuate  metabolic  repercussions.
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